ANVS

ANNOVIS BIO INC

ANVS·03615A108·US·Common Stock·Healthcare - Biotechnology-13D/G

ANVS (ANNOVIS BIO INC) is held by 27 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($2.6M), VANGUARD CAPITAL MANAGEMENT LLC ($1.9M), TWO SIGMA INVESTMENTS, LP ($1.4M). Net institutional sentiment: Mixed.

27
Holders
Avg rating(6 Elite)
$9.5M
Total Value
54% (34)
Fund Consensus
14 buying - 12 selling
ANVSSmart Money Verdict
View all
Held by 27 funds
6 elite
Who's Trading
InsiderHBHoffman Michael BBuy $1.5MApr 2, 2026
InsiderHBHoffman Michael BBuy $64KDec 8, 2025
InsiderHBHoffman Michael BBuy $130KDec 8, 2025
InsiderHBHoffman Michael BBuy $117KNov 24, 2025
InsiderHBHoffman Michael BBuy $2KNov 24, 2025
InsiderHBHoffman Michael BBuy $35KNov 24, 2025
InsiderHBHoffman Michael BBuy $6KNov 24, 2025
InsiderHBHoffman Michael BBuy $35KNov 21, 2025
InsiderHBHoffman Michael BBuy $35KNov 21, 2025
ActivistCICVI Investments, Inc.4.9%May 12, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.2M(+63.6%)$2.6M0.0%-40.34%
38
New
872,381$1.9M0.0%-27.91%
40
Increased
627,659(+13.7%)$1.4M0.0%-44.54%
29
New
347,600$775,1480.0%-27.91%
34
Increased
247,513(+11.4%)$552,2180.0%-83.77%
18
Decreased
218,336(-28.0%)$486,8890.0%-42.12%
0
Increased
141,730(+17.3%)$316,0580.0%-58.60%
19
Unchanged
139,533$311,1590.0%-57.69%
0
New
132,042$294,4540.0%-27.91%
32
Unchanged
81,316$181,3350.0%-73.79%
0
Increased
77,735(+5.0%)$173,3490.0%-79.57%
16
Increased
69,663(+0.8%)$155,3480.0%-54.52%
23
New
24,580$54,8130.0%-27.91%
29
Decreased
21,538(-29.7%)$48,0300.0%-46.00%
0
Unchanged
20,000$44,6000.0%-84.08%
0
Decreased
15,476(-22.8%)$34,5110.0%-96.33%
0
Unchanged
14,307$31,9050.0%-75.12%
0
Unchanged
14,900$29,9490.0%-30.82%
0
New
11,190$24,9540.0%-27.91%
29
Decreased
5,733(-42.1%)$12,7850.0%-25.16%
0

Showing 1-20 of 34

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used